Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016

31/05/2021

Changes in Sub. S-hldr's Int (Section 138 of CA 2016)

SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder

Name MR TEO YEK MING
Nationality/Country of incorporation Malaysia
Descriptions (Class) Ordinary Shares

Details of changes

No Date of change
No of securities
Type of Transaction Nature of Interest
28 May 2021
15,466,667
Others Direct Interest
Name of registered holder Teo Yek Ming
Description of "Others" Type of Transaction Allotment of Shares
28 May 2021
10,909,091
Others Indirect Interest
Name of registered holder RHB Capital Nominees (Tempatan) Sdn Bhd David Lai & Tan Services Sdn Bhd
Description of "Others" Type of Transaction Allotment of Shares

Circumstances by reason of which change has occurred Allotment of Consideration Shares arising from the Acquisition of Finsource Solution Sdn. Bhd. by Sunzen Biotech Berhad
Nature of interest Direct and Indirect Interest
Direct (units) 84,180,417
Direct (%) 14.7
Indirect/deemed interest (units) 11,035,091
Indirect/deemed interest (%) 1.93
Total no of securities after change 95,215,508
Date of notice 31 May 2021
Date notice received by Listed Issuer 31 May 2021


Remarks :
(1) Deemed interest by virtue of 126,000 shares held by parent.
(2) Deemed interest by virtue of 10,909,091 shares held as security by David Lai & Tan Services Sdn Bhd pursuant to Section 8 of the Companies Act 2016.


Announcement Info

Company Name SUNZEN BIOTECH BERHAD
Stock Name SUNZEN
Date Announced 31 May 2021
Category Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016
Reference Number CS2-15032021-00181